Insights into Company

Pfizer ↗

Biotechnology: Pharmaceutical Preparations company

📍 Mumbai, Maharashtra, United States Active NYSE PFE CIN L24231MH1950PLC008311 Pharmaceuticals & Healthcare
Search companies

Key Metrics of Pfizer

Revenue$59.6B▼ 41.1% YoYFY 2023
Operating income—
Net profit$2.1B▼ 93.2% YoY
Shareholders' equity$89.0B
Market cap$173BPFE · $30.42
Competitors10identified

About Pfizer

Sectors

Pharmaceuticals & HealthcareFormulations & Contract Manufacturing

Company details

Website
pfizer.com
Registered office
The Capital, 1802 / 1901,, Plot No. C-70, G Block,, Bandra Kurla Complex, Bandra (east), Mumbai Mumbai City, Mh In, Mumbai, In-mh, 400051
Listed
NYSE: PFE

Operational Areas of Pfizer

Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing

Company summary

Entity details

CINL24231MH1950PLC008311
LEI code335800XKH6F1JFLUBO78
State codeMH
PIN code400051
Current legal namePFIZER
Classification—
Listing statusListed
Registration no.008311
Company age—
PAN—
CountryUnited States
CityMumbai
StateMaharashtra
Current statusActive
Date of incorporation—
Registrar of companies—
Authorised capital—
Paid-up capital—
Employee count—

Compliance

Last AGM date—
Last balance sheet—
Next filing dueAOC-4 for FY 2025-26 · 30 Oct 2026

Industry classification

NIC code24231
Description of main activityManufacture of chemicals and chemical products (incl. pharmaceuticals)
Description of business activityManufacture of chemicals and chemical products (incl. pharmaceuticals)
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing

US market & SEC filings

PFE · NYSE  ·  SEC CIK 0000078003

Last price · 24 Oct 2026 $30.42 +1.91%
Market cap$173B
P/E82.2On FY 2023 diluted EPS
Volume28,703,433
SectorHealth CareBiotechnology: Pharmaceutical Preparations
Country · IPOUnited States

PFE share price

Premium

Annual results (SEC EDGAR)

Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.

Sign in to continue See plans & pricing

Filing compliance

AGM for FY 2025-2630 Sep 2026 Statutory due date passed
AOC-4 for FY 2025-2630 Oct 2026 Statutory due date · 5 days left
MGT-7 for FY 2025-2629 Nov 2026 Statutory due date · 35 days left

Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.

Vendor checks & payment capacity

Sign in with access to company financials to review vendor evidence.

Registered office and contact

Registered officeTHE CAPITAL, 1802 / 1901,, PLOT NO. C-70, G BLOCK,, BANDRA KURLA COMPLEX, BANDRA (EAST), MUMBAI MUMBAI CITY, MH IN, MUMBAI, IN-MH, 400051
GSTIN—
Email—
Websitehttps://www.pfizer.com
Members / shareholders—

Directors and key people

Directors are read from the MGT-7 annual return and AOC-4 signatories.

Competitors of Pfizer

Competitors10identified
Locations1most in United States

Top competitors by location

CompanyDescriptionDomainFoundedLocation
Eli Lilly and Company Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare lilly.com — United States
Johnson & Johnson Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare jjmt.com.tw — United States
Procter & Gamble Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare pg.com — United States
Merck & Co. Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare merck.com — United States
Amgen Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare amgen.com 1983 United States
Gilead Sciences Part of Gilead Sciences. gilead.com 1992 United States
Abbott Laboratories Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare abbott.com — United States
Bristol-Myers Squibb Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare bms.com — United States
Marriott International Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare marriott.com.cn — United States
HCA Healthcare Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare hcahealthcare.com 2011 United States

Similar companies

Charges (secured borrowings)

0 registered charges. Lenders, amounts and dates are part of the premium plan.

Statutory auditors

Auditors are read from the AOC-4 auditor's report section.

Group companies

Business activities and related parties

pharmaceutical industry

Filings

No filings on record yet.